News & events

Events

Inaugural International Conference on Public Health in Africa (CPHIA) 2021

21 October 2021
08:00 - 00:00

The invitation to submit an abstract is available for download below:

Opening of abstract submissions is Monday 4 October Deadline for abstract submission is Monday 8 November at 23:59hrs EAT and no abstracts will be accepted past the official due date Evaluation. All abstracts submitted will be
reviewed by a minimum of three independent CPHIA Abstract Submission

Overview Abstracts by Invitation Only:

The CPHIA organizers are pleased to invite abstracts on a specific set of pressing topics from a range of African institutions. For the inaugural CPHIA, there will not be an open call, and authors must receive an invitation in order to submit their work.

Topics:Abstracts will be accepted for 3 of the conference tracks:
• Track 1: Epidemiology of SARS-COV-2, Virology, Prevention and Clinical Management
• Track 4: Assessing the Response to COVID-19 in Africa to Prepare for Future Health Threats
• Track 6: Digitisation, Modelling and Analytics to Support an Effective Public Health Response to the COVID-19 Pandemic

Eligibility of Abstracts and Authors: Only abstracts with original work within the above topical areas will be accepted for the conference. The primary author must have participated in the activities showcased in the abstract and obtained the necessary government approvals where sensitive data is used in the paper as well any necessary ethical clearance documents. Only one abstract per person (primary author) will be considered for submission and research should have been conducted within the 2019-2021 period.

Abstracts that have been previously presented elsewhere will be considered, but priority will be given to abstracts that have not yet been presented at any other scientific conference. Authors should emphasize how the work undertaken was used to impact public health emergencies and outbreak preparedness, response and control in Africa, and/or how the research will change the course of public health practice in the future. Authors of abstracts that have not been previously published will have the opportunity to submit their manuscript to the Journal of Public Health in Africa for publication under a special CPHIA supplement Conflict of interest: Authors of accepted abstracts will have to submit a disclosure of conflict of interest form that will be shared with the acceptance letter. Abstract Submission procedures Authors should upload their abstracts via the web – based conference abstract management system/platform found at https://cphia2021.awardsplatform.com/. Should you have difficulties to navigate the platform contact CPHIA2021Abstracts@globalhealthstrategies.com.

Opening of abstract submissions is Monday 4 October

Deadline for abstract submission is Monday 8 November at 23:59hrs EAT and no abstracts will be accepted past the official due date

Evaluation. All abstracts submitted will be reviewed by a minimum of three independent subject matter experts in the area. Acceptance. Applicants will be notified of acceptances by Monday 29 November 2021 Structure of abstracts. Abstracts must include the following sections:

Title: The title should be informative but concise with no subtitles or abbreviations/ acronyms and should highlight what the study/subject is, where it was done and when it was undertaken (e.g., Cluster of COVID-19 cases in Keke district, August 2020).

Write the title in sentence case and only capitalize proper nouns and scientific names where appropriate e.g., Plasmodium falciparum. Introduction/Background: Address the scientific background, rationale for the study as well as the public health significance of the subject. Because of the anticipated diversity of the reviewers and those attending the conference, do not assume that everyone will be familiar with your topic.

Explain why your study is important and what question(s) it will answer. A clearly stated background sets the stage and should include:
– A brief description of the topic and its public health significance
– Study Objectives – Research questions or study hypothesis if applicable

Methods:

Describe the methods used for the study. Essential points to be included are:
– Study design
– Study setting
– Study population
– Eligibility criteria and case definitions if any
– Sample size and sampling methods
– Data management and analysis Results:

Present the significant findings (both positive and negative) of the study that are directly related to the study objectives. This section should not include discussion of the results. Provide both absolute numbers and their percentages/proportions, rates and ratios where applicable. Please note that since an abstract is a stand-alone and citable document, the results section should contain data.

It should not include such statements as “Data will be discussed.” If considerable work is still pending before the conference submission, please indicate that the results are preliminary. Conclusion: Be as concise as possible. Do not re-state data included in the results. This section may include: – An interpretation of key findings and their implications for public health practice – Public health actions that are recommended and/or have been implemented as a consequence of the study

Note:

Changes cannot be made to the final abstract after it has been submitted. However, in the event that significant changes are affected after submission of the abstract, the changes should be highlighted during abstract presentation.

Word count: The abstract should not exceed 300 words (includes sub-headings but does not include the title, key words, list of authors and their addresses).

Authors
First author: Provide first name, initials of the middle name (if any), and the last name e.g. Henry .M. Kuku
– Co-authors: List each co-author in order of contribution by typing their first and middle names as initials followed by their last name in full (e.g. J.N. Toto, C.H. Kwakweri)
– Provide the organizational affiliations of the first author and all co-authors
– Indicate the corresponding author with an asterix* and provide their email address and telephone number plus their alternate contacts Key words:
Please include 4 – 6 key words.

Evaluation Criteria Each abstract will be evaluated by three independent reviewers using the following criteria:
• Background and rationale of the study
• Appropriateness of methods
• Presentation of results
• Conclusion and interpretation of results
• Public health significance
• Overall clarity of the abstract
• Novelty of the study
• Relevance to conference track/theme For further details about the first International Conference on Public Health in Africa (CPHIA 2021) contact ElsamaniL@africa-union.org and CPHIA@globalhealthstrategies.com, or visit the conference website at https://cphia2021.com/home/.

General Information
Opening of abstract submissions is Monday 4 October

Deadline for abstract submission is Monday 8 November at 23:59hrs EAT and no abstracts will be accepted past the official due date

Evaluation. All abstracts submitted will be reviewed by a minimum of three independent

CPHIA Abstract Submission Overview

Abstracts by Invitation Only: The CPHIA organizers are pleased to invite abstracts on a specific set of pressing topics from a range of African institutions. For the inaugural CPHIA, there will not be an open call, and authors must receive an invitation in order to submit their work.

Topics: Abstracts will be accepted for 3 of the conference tracks:

• Track 1: Epidemiology of SARS-COV-2, Virology, Prevention and Clinical Management
• Track 4: Assessing the Response to COVID-19 in Africa to Prepare for Future Health Threats
• Track 6: Digitisation, Modelling and Analytics to Support an Effective Public Health Response to the COVID-19 Pandemic

Eligibility of Abstracts and Authors: Only abstracts with original work within the above topical areas will be accepted for the conference. The primary author must have participated in the activities showcased in the abstract and obtained the necessary government approvals where sensitive data is used in the paper as well any necessary ethical clearance documents.

Only one abstract per person (primary author) will be considered for submission and research should have been conducted within the 2019-2021 period. Abstracts that have been previously presented elsewhere will be considered, but priority will be given to abstracts that have not yet been presented at any other scientific conference. Authors should emphasize how the work undertaken was used to impact public health emergencies and outbreak preparedness, response and control in Africa, and/or how the research will change the course of public health practice in the future.

Authors of abstracts that have not been previously published will have the opportunity to submit their manuscript to the Journal of Public Health in Africa for publication under a special CPHIA supplement

Conflict of interest: Authors of accepted abstracts will have to submit a disclosure of conflict of interest form that will be shared with the acceptance letter.

Abstract Submission procedures

Authors should upload their abstracts via the web – based conference abstract management system/platform found at https://cphia2021.awardsplatform.com/. Should you have difficulties to navigate the platform contact CPHIA2021Abstracts@globalhealthstrategies.com.

Opening of abstract submissions is Monday 4 October

Deadline for abstract submission is Monday 8 November at 23:59hrs EAT and no abstracts will be accepted past the official due date

Evaluation. All abstracts submitted will be reviewed by a minimum of three independent

subject matter experts in the area.

Acceptance. Applicants will be notified of acceptances by Monday 29 November 2021 Structure of abstracts. Abstracts must include the following sections:
Title: The title should be informative but concise with no subtitles or abbreviations/ acronyms and should highlight what the study/subject is, where it was done and when it was undertaken (e.g., Cluster of COVID-19 cases in Keke district, August 2020). Write the title in sentence case and only capitalize proper nouns and scientific names where appropriate e.g., Plasmodium falciparum.

Introduction/Background: Address the scientific background, rationale for the study as well as the public health significance of the subject. Because of the anticipated diversity of the reviewers and those attending the conference, do not assume that everyone will be familiar with your topic. Explain why your study is important and what question(s) it will answer.
A clearly stated background sets the stage and should include:
– A brief description of the topic and its public health significance
– Study Objectives
– Research questions or study hypothesis if applicable

Methods: Describe the methods used for the study. Essential points to be included are:
– Study design
– Study setting
– Study population
– Eligibility criteria and case definitions if any
– Sample size and sampling methods
– Data management and analysis

Results: Present the significant findings (both positive and negative) of the study that are directly related to the study objectives. This section should not include discussion of the results. Provide both absolute numbers and their percentages/proportions, rates and ratios where applicable.
Please note that since an abstract is a stand-alone and citable document, the results section should contain data. It should not include such statements as “Data will be discussed.” If considerable work is still pending before the conference submission, please indicate that the results are preliminary.

Conclusion: Be as concise as possible. Do not re-state data included in the results. This section may include:
– An interpretation of key findings and their implications for public health practice
– Public health actions that are recommended and/or have been implemented as a consequence of the study

Note: Changes cannot be made to the final abstract after it has been submitted. However, in the event that significant changes are affected after submission of the abstract, the changes should be highlighted during abstract presentation.

Word count: The abstract should not exceed 300 words (includes sub-headings but does not include the title, key words, list of authors and their addresses).

Authors
– First author: Provide first name, initials of the middle name (if any), and the last name e.g. Henry .M. Kuku
– Co-authors: List each co-author in order of contribution by typing their first and middle names as initials followed by their last name in full (e.g. J.N. Toto, C.H. Kwakweri)
– Provide the organizational affiliations of the first author and all co-authors
– Indicate the corresponding author with an asterix* and provide their email address and telephone number plus their alternate contacts

Key words: Please include 4 – 6 key words.

Evaluation Criteria
Each abstract will be evaluated by three independent reviewers using the following criteria:
• Background and rationale of the study
• Appropriateness of methods
• Presentation of results
• Conclusion and interpretation of results
• Public health significance
• Overall clarity of the abstract
• Novelty of the study
• Relevance to conference track/theme

For further details about the first International Conference on Public Health in Africa (CPHIA 2021) contact ElsamaniL@africa-union.org and CPHIA@globalhealthstrategies.com, or visit the conference website at https://cphia2021.com/home/.